Citations 0
Invited Critique
December 15, 2008

Perioperative Carcinoembryonic Antigen Measurements to Predict Curability After Liver Resection for Colorectal Metastases—Invited Critique

Author Affiliations

Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2008

Arch Surg. 2008;143(12):1158-1159. doi:10.1001/archsurg.143.12.1158

Hepatic resection is the only curative option for patients with hepatic metastases from colorectal cancer (CRC). Five-year survival rates after resection have reached almost 60% in recent series.13 This is largely attributed to more sophisticated preoperative imaging techniques, highly sensitive intraoperative ultrasonographic detection of small metastases, improved surgical techniques, and more effective systemic therapies.3,4

First Page Preview View Large
First page PDF preview
First page PDF preview